BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 24239213)

  • 1. Pharmacist, general practitioner and consumer use of written medicine information in Australia: are they on the same page?
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2014; 10(4):656-68. PubMed ID: 24239213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing provision of written medicine information in Australia: pharmacist, general practitioner and consumer perceptions of the barriers and facilitators.
    Hamrosi KK; Raynor DK; Aslani P
    BMC Health Serv Res; 2014 Apr; 14():183. PubMed ID: 24754890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacist and general practitioner ambivalence about providing written medicine information to patients-a qualitative study.
    Hamrosi KK; Raynor DK; Aslani P
    Res Social Adm Pharm; 2013; 9(5):517-30. PubMed ID: 23567071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacists' and consumers' viewpoints on counselling on prescription medicines in Australian community pharmacies.
    Puspitasari HP; Aslani P; Krass I
    Int J Pharm Pract; 2010 Aug; 18(4):202-8. PubMed ID: 20636671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifestyle or life-saving medicines? A primary healthcare professional and consumer opinion survey on over-the-counter statins.
    Vamvakopoulos JE; Kountouri M; Marshall T; Greenfield SM
    Ann Pharmacother; 2008 Mar; 42(3):413-20. PubMed ID: 18303145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a measure and a model of general practitioner attitudes toward collaboration with pharmacists.
    Van C; Costa D; Mitchell B; Abbott P; Krass I
    Res Social Adm Pharm; 2013; 9(6):688-99. PubMed ID: 23395533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceived feasibility of a community pharmacy-based asthma intervention: a qualitative follow-up study.
    Bereznicki B; Peterson G; Jackson S; Haydn Walters E; DeBoos I; Hintz P
    J Clin Pharm Ther; 2011 Jun; 36(3):348-55. PubMed ID: 21545614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do medication samples jeopardize patient safety?
    Franks AS; Ray SM; Wallace LS; Keenum AJ; Weiss BD
    Ann Pharmacother; 2009 Jan; 43(1):51-6. PubMed ID: 19092144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doctors and pharmacists provision and opinions of medicines information leaflets in New Zealand.
    Young A; Tordoff J; Leitch S; Smith A
    Int J Clin Pharm; 2018 Jun; 40(3):676-685. PubMed ID: 29675683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concordance-based adherence support service delivery: consumer perspectives.
    Du Pasquier S; Aslani P
    Pharm World Sci; 2008 Dec; 30(6):846-53. PubMed ID: 18592393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consumer-pharmacist interactions around complementary medicines: agreement between pharmacist and consumer expectations, satisfaction and pharmacist influence.
    Tran S; Calabretto JP; Sorich M
    Int J Pharm Pract; 2013 Dec; 21(6):378-85. PubMed ID: 23517229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of written medicine information: validation of the Consumer Information Rating Form.
    Koo MM; Krass I; Aslani P
    Ann Pharmacother; 2007 Jun; 41(6):951-6. PubMed ID: 17488832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient characteristics influencing evaluation of written medicine information: lessons for patient education.
    Koo MM; Krass I; Aslani P
    Ann Pharmacother; 2005 Sep; 39(9):1434-40. PubMed ID: 16046486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. General practitioners' views of pharmacists' current and potential contributions to medication review and prescribing in New Zealand.
    Hatah E; Braund R; Duffull SB; Tordoff J
    J Prim Health Care; 2013 Sep; 5(3):223-33. PubMed ID: 23998173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physician and pharmacist perceptions of generic medicines: what they think and how they differ.
    Dunne S; Shannon B; Hannigan A; Dunne C; Cullen W
    Health Policy; 2014 Jun; 116(2-3):214-23. PubMed ID: 24709114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the General Practitioner-pharmacist relationship in the community setting in Ireland.
    Moore T; Kennedy J; McCarthy S
    Int J Pharm Pract; 2014 Oct; 22(5):327-34. PubMed ID: 24433551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of medicines information in Australian community pharmacies.
    Vitry A; Gilbert A; Mott K; Rao D; March G
    Pharm World Sci; 2009 Apr; 31(2):154-7. PubMed ID: 19229651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes from a regular medication information programme for consumers with a mental illness.
    Tran N; Castle D
    Australas Psychiatry; 2012 Apr; 20(2):143-7. PubMed ID: 22461659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Community pharmacists in Australia: barriers to information provision on complementary and alternative medicines.
    Semple SJ; Hotham E; Rao D; Martin K; Smith CA; Bloustien GF
    Pharm World Sci; 2006 Dec; 28(6):366-73. PubMed ID: 17120131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A qualitative exploration of opinions on the community pharmacists' role amongst the general public in Scotland.
    Gidman W; Cowley J
    Int J Pharm Pract; 2013 Oct; 21(5):288-96. PubMed ID: 23418884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.